1000+ types of tissue microarray

TISSUE ARRAYS

B-63End-1

Endometrioid cancer tissue array, including pathology grade, TNM and clinical stage, 63 cases/63 cores

Zoom

B-63End-1

Cores

Cases

Row number

Column number

Core Diameter(mm)

1.5

Thickness(µm)

5.0

Tissue Array Type

FFPE

Species

Human

QA/QC

H&E and IHC confirmed

Applications

Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.

Notes

1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better.

2.Bake the slides for 60 minutes at 65℃ before the experiment.

3.Please choose a gentle repair method to avoid tissue detachment.

Legend:

Ute

-Uterus

Malignant (IA)

Malignant (IB)

Malignant (II)

Malignant (IIB)

Malignant (IIIA)

Malignant (IIIC)

NAT (*)

Normal (*)

TISSUE ARRAYS B-63End-1

	1	2	3	4	5	6	7	8	9
A	UTE	UTE	UTE	UTE	UTE	UTE	UTE	UTE	UTE
B	UTE	UTE	UTE	UTE	UTE	UTE	UTE	UTE	UTE
C	UTE	UTE	UTE	UTE	UTE	UTE	UTE	UTE	UTE
D	UTE	UTE	UTE	UTE	UTE	UTE	UTE	UTE	UTE
E	UTE	UTE	UTE	UTE	UTE	UTE	UTE	UTE	UTE
F	UTE	UTE	UTE	UTE	UTE	UTE	UTE	UTE	UTE
G	UTE	UTE	UTE	UTE	UTE	UTE	UTE	UTE	UTE

Pos	No	Age	Sex	Organ_Anatomic_Site	Pathology_diagnosis	Grade	TNM	Stage	Type	Tumor Size
A1	1	35	F	Uterus	Endometrioid adenocarcinoma (sparse)	1	T2N0M0	II	Malignant	*
A2	2	57	F	Uterus	Endometrioid adenocarcinoma	1	T1aN0M0	IA	Malignant	*
A3	3	57	F	Uterus	Endometrioid adenocarcinoma (sparse)	1	T1bN0M0	IB	Malignant	*
A4	4	38	F	Uterus	Endometrioid adenocarcinoma	1	T1bN0M0	IB	Malignant	*
A5	5	49	F	Uterus	Endometrioid adenocarcinoma	1	T1aN0M0	IA	Malignant	5*5
A6	6	47	F	Uterus	Endometrioid adenocarcinoma	1	T1bN0M0	IB	Malignant	9*9
A7	7	56	F	Uterus	Endometrioid adenocarcinoma	1	T1aN0M0	IA	Malignant	32.51.2
A8	8	53	F	Uterus	Endometrioid adenocarcinoma	1	T1aN0M0	IA	Malignant	644
A9	9	54	F	Uterus	Endometrioid adenocarcinoma	1	T1aN0M0	IA	Malignant	2.520.5
B1	10	50	F	Uterus	Endometrioid adenocarcinoma	1	T1bN0M0	IB	Malignant	11104
B2	11	37	F	Uterus	Endometrioid adenocarcinoma	1	T1bN0M0	IB	Malignant	64.53
B3	12	53	F	Uterus	Endometrioid adenocarcinoma (sparse)	1	T1aN0M0	IA	Malignant	988
B4	13	68	F	Uterus	Endometrioid adenocarcinoma	1	T1bN0M0	IB	Malignant	744
B5	14	54	F	Uterus	Endometrioid adenocarcinoma	1	T1bN0M0	IB	Malignant	21.51
B6	15	43	F	Uterus	Endometrioid adenocarcinoma	1	T1bN0M0	IB	Malignant	876
B7	16	49	F	Uterus	Endometrioid adenocarcinoma	1	T1aN0M0	IA	Malignant	2.5*1
B8	17	50	F	Uterus	Endometrioid adenocarcinoma	1	T1aN0M0	IA	Malignant	4*2
B9	18	43	F	Uterus	Endometrioid adenocarcinoma	1	T1aN0M0	IA	Malignant	2*2
C1	19	53	F	Uterus	Endometrioid adenocarcinoma	1	T2N0M0	II	Malignant	994
C2	20	37	F	Uterus	Endometrioid adenocarcinoma	1	T1bN0M0	IB	Malignant	431.5
C3	21	33	F	Uterus	Endometrioid adenocarcinoma	1--2	T1bN0M0	IB	Malignant	1194
C4	22	56	F	Uterus	Endometrioid adenocarcinoma	2	T1bN0M0	IB	Malignant	5*3.5
C5	23	70	F	Uterus	Endometrioid adenocarcinoma	2	T1bN1M0	IIIC	Malignant	644
C6	24	52	F	Uterus	Endometrioid adenocarcinoma	2	T1bN0M0	IB	Malignant	432
C7	25	46	F	Uterus	Endometrioid adenocarcinoma	2	T1bN0M0	IB	Malignant	3.520.8
C8	26	61	F	Uterus	Endometrioid adenocarcinoma	2	T2N0M0	II	Malignant	3*2
C9	27	70	F	Uterus	Endometrioid adenocarcinoma	2	T1aN0M0	IA	Malignant	93.52.5
D1	28	30	F	Uterus	Endometrioid adenocarcinoma	2	T1bN0M0	IB	Malignant	*
D2	29	57	F	Uterus	Endometrioid adenocarcinoma	2	T1bN0M0	IB	Malignant	*
D3	30	52	F	Uterus	Endometrioid adenocarcinoma	2	T1aN0M0	IA	Malignant	*
D4	31	58	F	Uterus	Endometrioid adenocarcinoma (sparse)	2	T1aN0M0	IA	Malignant	*
D5	32	46	F	Uterus	Endometrioid adenocarcinoma	2	T1aN0M0	IA	Malignant	*
D6	33	74	F	Uterus	Endometrioid adenocarcinoma	2	T1bN0M0	IB	Malignant	332
D7	34	59	F	Uterus	Endometrioid adenocarcinoma	2	T1bN0M0	IB	Malignant	832.5
D8	35	54	F	Uterus	Endometrioid adenocarcinoma	2	T2N0M0	II	Malignant	2.521
D9	36	50	F	Uterus	Endometrioid adenocarcinoma	2	T1bN0M0	IB	Malignant	3*2
E1	37	70	F	Uterus	Endometrioid adenocarcinoma	2	T2N0M0	II	Malignant	1.54.52
E2	38	52	F	Uterus	Endometrioid adenocarcinoma	2	T1bN0M0	IB	Malignant	432
E3	39	68	F	Uterus	Endometrioid adenocarcinoma	2	T3aN0M0	IIIA	Malignant	864
E4	40	54	F	Uterus	Endometrioid adenocarcinoma with necrosis	2	T1aN0M0	IA	Malignant	953
E5	41	50	F	Uterus	Endometrioid adenocarcinoma	2	T3aN0M0	IIIA	Malignant	642.5
E6	42	58	F	Uterus	Endometrioid adenocarcinoma	2	T1bN0M0	IB	Malignant	533
E7	43	43	F	Uterus	Endometrioid adenocarcinoma	2	T1bN0M0	IB	Malignant	733
E8	44	79	F	Uterus	Endometrioid adenocarcinoma	2	T1aN0M0	IA	Malignant	430.8
E9	45	60	F	Uterus	Endometrioid adenocarcinoma	2	T1bN0M0	IB	Malignant	553
F1	46	63	F	Uterus	Endometrioid adenocarcinoma with necrosis	2--3	T3aN0M0	IIIA	Malignant	932.5
F2	47	58	F	Uterus	Endometrioid adenocarcinoma with necrosis	2--3	T1bN0M0	IB	Malignant	1097
F3	48	49	F	Uterus	Endometrioid adenocarcinoma	3	T2N0M0	II	Malignant	554
F4	49	53	F	Uterus	Endometrioid adenocarcinoma	3	T3aN0M0	IIIA	Malignant	764
F5	50	60	F	Uterus	Endometrioid adenocarcinoma	3	T1aN0M0	IA	Malignant	432.5
F6	51	51	F	Uterus	Endometrioid adenocarcinoma	3	T1bN0M0	IB	Malignant	84.54.5
F7	52	51	F	Uterus	Endometrioid adenocarcinoma	3	T3aN0M0	IIIA	Malignant	4*3
F8	53	53	F	Uterus	Endometrioid adenocarcinoma	3	T1bN0M0	IB	Malignant	42.51.5
F9	54	62	F	Uterus	Endometrioid adenocarcinoma	3	T1bN0M0	IB	Malignant	3.531.2
G1	55	43	F	Uterus	Endometrioid adenocarcinoma with necrosis	3	T1bN0M0	IB	Malignant	3.532.5
G2	56	66	F	Uterus	Endometrioid adenocarcinoma	3	T3aN0M0	IIIA	Malignant	*
G3	57	63	F	Uterus	Endometrioid adenocarcinoma	3	T1bN0M0	IB	Malignant	*
G4	58	55	F	Uterus	Endometrioid adenocarcinoma	3	T1bN0M0	IB	Malignant	*
G5	59	52	F	Uterus	Endometrioid adenocarcinoma	3	T2bN0M0	IIB	Malignant	*
G6	60	62	F	Uterus	Endometrioid adenocarcinoma	3	T1bN0M0	IB	Malignant	321
G7	61	52	F	Uterus	Endometrial tissue	*	*	*	NAT	*
G8	62	46	F	Uterus	Endometrial tissue	*	*	*	NAT	*
G9	63	54	F	Uterus	Endometrial tissue	*	*	*	Normal	*
Tissue Marker